SGP - Spyglass Pharma, Inc.

Insider Purchase by Pardo Geoffrey B (Dir)

3 Months
After Trade
Before Trade

Loading data...

Trade Summary

1 month ago, Pardo Geoffrey B, serving as Dir at Spyglass Pharma, Inc. (SGP), purchased 312,500 shares at $16.00 per share, for a total transaction value of $5,000,000.00. Following this transaction, Pardo Geoffrey B now holds 2,187,513 shares of SGP.

This purchase represents a 17.00% increase in Pardo Geoffrey B's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 11, 2026, 2 days after the trade was made.

Spyglass Pharma, Inc. operates in the NONE sector, specifically within the NONE industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Pardo Geoffrey B

Pardo Geoffrey B

Dir

Geoffrey B. Pardo is a seasoned medtech investor and executive serving as an Independent Director at Shoulder Innovations, Inc. (SI) since 2023.[[1]](https://shoulderinnovations.com/leadership-team/)[[5]](https://gildehealthcare.com/team/venture-and-growth/geoff-pardo/)[[6]](https://ca.marketscreener.com/insider/GEOFF-B-PARDO-A091CI/) He recently purchased 100,000 shares of Shoulder Innovations at $15 per share, investing approximately $1.5 million, signaling strong confidence in the company.[[3]](https://www.waiker.ai/data-lab/waiker-news/6255)[[4]](https://www.quiverquant.com/news/SHOULDER+INNOVATIONS+Earnings+Results:+$SI+Reports+Quarterly+Earnings) Pardo joined Gilde Healthcare in 2011 as a Partner (now General Partner) in their Boston/Cambridge office, leading investments in North America including Inari Medical (NASDAQ: NARI), Axonics (NASDAQ: AXNX), CVRx, and Shoulder Innovations.[[2]](https://medtechmvp.com/biographies/Geoff-Pardo)[[5]](https://gildehealthcare.com/team/venture-and-growth/geoff-pardo/) Previously, he was President & CEO of Facet Solutions, a spinal implant company treating lumbar spinal stenosis, until its sale to Globus Medical in 2011; Partner at Spray Venture Partners, leading deals like Interlace Medical (sold to Hologic); and an Associate at Cardinal Partners.[[1]](https://shoulderinnovations.com/leadership-team/)[[2]](https://medtechmvp.com/biographies/Geoff-Pardo) He began his career as a product manager at Synthes USA and holds a BA with honors in History from Brown University and an MBA from The Wharton School.[[1]](https://shoulderinnovations.com/leadership-team/)[[2]](https://medtechmvp.com/biographies/Geoff-Pardo)

View full insider profile →

Trade Price

$16.00

Quantity

312,500

Total Value

$5,000,000.00

Shares Owned

2,187,513

Trade Date

Monday, February 9, 2026

55 days ago

SEC Filing Date

Wednesday, February 11, 2026

Filed 2 days after trade

NONENONE

About Spyglass Pharma, Inc.

Company Overview

No company information available
View news mentioning SGP

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3897851

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime